KURN — Kuros Biosciences AG Cashflow Statement
0.000.00%
Last trade - 00:00- CH₣252.78m
- CH₣240.72m
- CH₣33.56m
Annual cashflow statement for Kuros Biosciences AG, fiscal year end - December 31st, CHF millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -11.8 | -12.1 | -9.55 | -16 | -13.3 |
| Depreciation | |||||
| Non-Cash Items | -0.241 | 0.966 | 1.57 | 7.15 | 5.58 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.5 | -0.78 | -0.352 | -1.34 | -3.83 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -10.8 | -9.24 | -5.45 | -7.35 | -8.84 |
| Capital Expenditures | -0.118 | -0.22 | -0.374 | -0.4 | -0.326 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | -0.118 | -0.22 | -0.374 | -0.4 | -0.326 |
| Financing Cash Flow Items | -0.957 | -1.37 | 0 | -2.43 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 13.1 | 17.1 | 6.08 | 3.22 | -0.171 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.47 | 7.59 | 0.241 | -4.56 | -9.86 |